Impact of chemotherapy and other prognostic factors on survival in advanced non-small cell lung cancer at Hospital Kuala Lumpur, Malaysia / Nida Sajid Ali Bangash

Determining vital prognostic factors of survival including appropriate chemotherapy regimens in patients with non-small cell lung cancer (NSCLC) is challenging due to increased prevalence and progressive nature of disease. The main objectives of this present study were to describe the prognostic fac...

Full description

Saved in:
Bibliographic Details
Main Author: Ali Bangash, Nida Sajid
Format: Thesis
Language:English
Published: 2017
Subjects:
Online Access:https://ir.uitm.edu.my/id/eprint/37988/1/37988.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
id my-uitm-ir.37988
record_format uketd_dc
spelling my-uitm-ir.379882022-09-14T13:43:06Z Impact of chemotherapy and other prognostic factors on survival in advanced non-small cell lung cancer at Hospital Kuala Lumpur, Malaysia / Nida Sajid Ali Bangash 2017 Ali Bangash, Nida Sajid Cancer Radiotherapy Determining vital prognostic factors of survival including appropriate chemotherapy regimens in patients with non-small cell lung cancer (NSCLC) is challenging due to increased prevalence and progressive nature of disease. The main objectives of this present study were to describe the prognostic factors of adult NSCLC patients via their demographic and medical data, to investigate the relationship (association and prediction) of NSCLC stage, epidermal growth factor receptor (EGFR) status and Eastern Cooperative Oncology Group (ECOG) performance status (PS) among independent variables from patients' demographic and medical data, to determine the impact of treatment groups, CT groups and lines of CT groups on survival in adult NSCLC patients, to compare survival among treatment groups, CT groups and lines of CT groups in adult NSCLC patients and to assess the impact of study predictor variables on death. This retrospective cohort study included adult (> 18 years old) NSCLC patients (n = 235) using purposive sampling method. The study was conducted in the Radiotherapy and Oncology Clinic and ward at Hospital Kuala Lumpur (HKL), Malaysia. The mean (± SD) age of adult NSCLC patients was 56.7 (±10.1) years old. Majority were males, Chinese, had adenocarcinoma, stage IV NSCLC, non-smokers with unknown EGFR status and ECOG PS score of 2. The most common site of metastasis was lung followed by bone, and most prevalent comorbidity was hypertension (HTN). Using Chi-square test, only sites of metastasis had significant association with NSCLC stage. For EGFR status, independent study variables that had significant association were age, gender, histopathology, smoking status and ECOG PS. Furthermore, ECOG PS was significantly associated with age, body weight and EGFR status. Using multinomial logistic regression analysis, the site of metastasis was the only significant predictor to NSCLC stage. Gender and histology were the significant predictors for EGFR status. The findings of binary logistic regression showed that histopathology was the only significant predictor for EGFR status. The Kaplan Meier (K-M) survival test and log-rank test suggested that for treatment groups, CT improved overall survival (OS); for CT groups, nonplatinum based (NPB) therapy showed better OS; and for lines of CT groups, only first-line tyrosine kinase inhibitors (TKIs) showed superiority for OS. The results of Cox proportional hazard (PH) regression model for treatment groups, lines of CT groups and selected study independent variables from demographic and medical data concluded that CT, RT (treatment groups), first-line TKIs, Indian (ethnicity), stage IIIA NSCLC, adenocarcinoma lung cancer (histopathology), positive-negative EGFR status and ECOG PS score of 0 and 2 were significant predictors forbetter survival, whereas PB therapy (chemotherapy groups), Malay and Chinese (ethnicity) and smokers (smoking status) were significant predictors for worse survival in locally advanced or metastatic NSCLC patients. The present study suggested the CT administered and various prognostic factors are capable of influencing survival in adult NSCLC patients. 2017 Thesis https://ir.uitm.edu.my/id/eprint/37988/ https://ir.uitm.edu.my/id/eprint/37988/1/37988.pdf text en public masters Universiti Teknologi MARA (UiTM) Faculty of Pharmacy Ismail, Nahlah Elkudssiah
institution Universiti Teknologi MARA
collection UiTM Institutional Repository
language English
advisor Ismail, Nahlah Elkudssiah
topic Cancer
Radiotherapy
spellingShingle Cancer
Radiotherapy
Ali Bangash, Nida Sajid
Impact of chemotherapy and other prognostic factors on survival in advanced non-small cell lung cancer at Hospital Kuala Lumpur, Malaysia / Nida Sajid Ali Bangash
description Determining vital prognostic factors of survival including appropriate chemotherapy regimens in patients with non-small cell lung cancer (NSCLC) is challenging due to increased prevalence and progressive nature of disease. The main objectives of this present study were to describe the prognostic factors of adult NSCLC patients via their demographic and medical data, to investigate the relationship (association and prediction) of NSCLC stage, epidermal growth factor receptor (EGFR) status and Eastern Cooperative Oncology Group (ECOG) performance status (PS) among independent variables from patients' demographic and medical data, to determine the impact of treatment groups, CT groups and lines of CT groups on survival in adult NSCLC patients, to compare survival among treatment groups, CT groups and lines of CT groups in adult NSCLC patients and to assess the impact of study predictor variables on death. This retrospective cohort study included adult (> 18 years old) NSCLC patients (n = 235) using purposive sampling method. The study was conducted in the Radiotherapy and Oncology Clinic and ward at Hospital Kuala Lumpur (HKL), Malaysia. The mean (± SD) age of adult NSCLC patients was 56.7 (±10.1) years old. Majority were males, Chinese, had adenocarcinoma, stage IV NSCLC, non-smokers with unknown EGFR status and ECOG PS score of 2. The most common site of metastasis was lung followed by bone, and most prevalent comorbidity was hypertension (HTN). Using Chi-square test, only sites of metastasis had significant association with NSCLC stage. For EGFR status, independent study variables that had significant association were age, gender, histopathology, smoking status and ECOG PS. Furthermore, ECOG PS was significantly associated with age, body weight and EGFR status. Using multinomial logistic regression analysis, the site of metastasis was the only significant predictor to NSCLC stage. Gender and histology were the significant predictors for EGFR status. The findings of binary logistic regression showed that histopathology was the only significant predictor for EGFR status. The Kaplan Meier (K-M) survival test and log-rank test suggested that for treatment groups, CT improved overall survival (OS); for CT groups, nonplatinum based (NPB) therapy showed better OS; and for lines of CT groups, only first-line tyrosine kinase inhibitors (TKIs) showed superiority for OS. The results of Cox proportional hazard (PH) regression model for treatment groups, lines of CT groups and selected study independent variables from demographic and medical data concluded that CT, RT (treatment groups), first-line TKIs, Indian (ethnicity), stage IIIA NSCLC, adenocarcinoma lung cancer (histopathology), positive-negative EGFR status and ECOG PS score of 0 and 2 were significant predictors forbetter survival, whereas PB therapy (chemotherapy groups), Malay and Chinese (ethnicity) and smokers (smoking status) were significant predictors for worse survival in locally advanced or metastatic NSCLC patients. The present study suggested the CT administered and various prognostic factors are capable of influencing survival in adult NSCLC patients.
format Thesis
qualification_level Master's degree
author Ali Bangash, Nida Sajid
author_facet Ali Bangash, Nida Sajid
author_sort Ali Bangash, Nida Sajid
title Impact of chemotherapy and other prognostic factors on survival in advanced non-small cell lung cancer at Hospital Kuala Lumpur, Malaysia / Nida Sajid Ali Bangash
title_short Impact of chemotherapy and other prognostic factors on survival in advanced non-small cell lung cancer at Hospital Kuala Lumpur, Malaysia / Nida Sajid Ali Bangash
title_full Impact of chemotherapy and other prognostic factors on survival in advanced non-small cell lung cancer at Hospital Kuala Lumpur, Malaysia / Nida Sajid Ali Bangash
title_fullStr Impact of chemotherapy and other prognostic factors on survival in advanced non-small cell lung cancer at Hospital Kuala Lumpur, Malaysia / Nida Sajid Ali Bangash
title_full_unstemmed Impact of chemotherapy and other prognostic factors on survival in advanced non-small cell lung cancer at Hospital Kuala Lumpur, Malaysia / Nida Sajid Ali Bangash
title_sort impact of chemotherapy and other prognostic factors on survival in advanced non-small cell lung cancer at hospital kuala lumpur, malaysia / nida sajid ali bangash
granting_institution Universiti Teknologi MARA (UiTM)
granting_department Faculty of Pharmacy
publishDate 2017
url https://ir.uitm.edu.my/id/eprint/37988/1/37988.pdf
_version_ 1783734446606778368